Home / Publications / Further guidance for life science companies if there...

Further guidance for life science companies if there is no Brexit deal

10/01/2019

Updated guidance has been issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) on how the UK would regulate medicines, medical devices and clinical trials in the event that the UK leaves the EU on 29 March 2019 with no withdrawal arrangements...

Read more

Authors

Portrait ofSarah Hanson
Sarah Hanson
Partner
London